USING A PANEL SURVEY TO IDENTIFY PREDICTORS OF DISEASE-MODIFYING DRUG ADHERENCE IN PATIENTS WITH MULTIPLE SCLEROSIS

被引：2
|
作者：
Phillips, A. L. [1 ]
Kozma, C. M.
Locklear, J. C. [1 ]
机构：
[1] EMD Serono Inc, Rockland, MA USA
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 07期
关键词：
D O I：
10.1016/j.jval.2014.08.910
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PND56
引用
收藏
页码：A400 / A400
页数：1
相关论文
共 50 条
  • [21] Factors that influence adherence with disease-modifying therapy in multiple sclerosis
    Treadaway, K
    Hawker, K
    Racke, M
    Brannon, K
    Morrison, A
    Remington, G
    Frohman, E
    Cohen, B
    Corboy, J
    Simsarian, J
    Lynch, S
    Jeffery, D
    MULTIPLE SCLEROSIS, 2005, 11 : S158 - S158
  • [22] Factors that influence adherence with disease-modifying therapy in multiple sclerosis
    Treadaway, KD
    Brannon, KD
    Morrison, A
    Remington, GM
    Olek, M
    Racke, MK
    Frohman, EM
    NEUROLOGY, 2006, 66 (05) : A30 - A30
  • [23] Adherence to disease-modifying therapies for multiple sclerosis and subsequent hospitalizations
    Evans, Charity
    Marrie, Ruth Ann
    Zhu, Feng
    Leung, Stella
    Lu, Xinya
    Kingwell, Elaine
    Zhao, Yinshan
    Tremlett, Helen
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 (06) : 702 - 711
  • [24] Using disease-modifying therapies for multiple sclerosis
    不详
    JOURNAL OF ADVANCED NURSING, 2004, 48 (03) : 314 - 314
  • [25] Relationship between severe relapses and adherence to disease-modifying therapy in multiple sclerosis patients
    Meletiche, D.
    Kozma, C.
    Bennett, R.
    AL-Sabbagh, A.
    JOURNAL OF NEUROLOGY, 2008, 255 : 205 - 205
  • [26] Narrative Review of the Literature on Adherence to Disease-Modifying Therapies Among Patients with Multiple Sclerosis
    Menzin, Joseph
    Caon, Christina
    Nichols, Christine
    White, Leigh Ann
    Friedman, Mark
    Pill, Michael W.
    JOURNAL OF MANAGED CARE PHARMACY, 2013, 19 (01): : S24 - S40
  • [27] Association between multiple sclerosis disease severity and adherence to disease-modifying therapies
    Burkhard, Adam
    Toliver, Joshua
    Rascati, Karen
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2021, 27 (07): : 915 - 923
  • [28] Comparative adherence trajectories of oral disease-modifying agents in multiple sclerosis
    Earla, Jagadeswara Rao
    Li, Jieni
    Hutton, George J.
    Johnson, Michael L.
    Aparasu, Rajender R.
    PHARMACOTHERAPY, 2023, 43 (06): : 473 - 484
  • [29] An evaluation of adherence in patients with multiple sclerosis newly initiating treatment with a self-injectable or an oral disease-modifying drug
    Munsell, Michael
    Frean, Molly
    Menzin, Joseph
    Phillips, Amy L.
    PATIENT PREFERENCE AND ADHERENCE, 2017, 11 : 55 - 62
  • [30] Baseline predictors of persistence to first disease-modifying treatment in multiple sclerosis
    Zettl, U. K.
    Schreiber, H.
    Bauer-Steinhusen, U.
    Glaser, T.
    Hechenbichler, K.
    Hecker, M.
    ACTA NEUROLOGICA SCANDINAVICA, 2017, 136 (02): : 116 - 121
12345